ENDRA Life Sciences (NDRA) Price to Book (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Price to Book for 10 consecutive years, with 1.27 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 29.33% year-over-year to 1.27 in Q2 2026; TTM through Jun 2026 was 1.27, a 29.33% decrease from a year earlier, with the FY2025 full-year figure at 1.58, up 219.23% from the prior year.
• Price to Book was 1.27 for Q2 2026 at ENDRA Life Sciences, down from 3.23 in the prior quarter.
• Over five years, Price to Book peaked at 83.44 in Q4 2023 and troughed at 0.26 in Q3 2024.
• A 5-year average of 32.36 and a median of 31.67 in 2025 frame the typical range for Price to Book.
• Across the five-year window, Price to Book slumped 99.58% in 2024 and jumped 9303.0% in 2025, its largest moves.
• Over 5 years, Price to Book stood at 62.66 in 2022, then soared by 33.16% to 83.44 in 2023, then slumped by 99.41% to 0.49 in 2024, then surged by 219.23% to 1.58 in 2025, then decreased by 19.68% to 1.27 in 2026.
• The last three Price to Book figures came in at 1.27 (Q2 2026), 3.23 (Q1 2026), and 1.58 (Q4 2025), per Business Quant data.